Literature DB >> 8429212

Responsiveness of the interleukin (IL)-6-dependent cell line B9 to IL-11.

R Burger, M Gramatzki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8429212     DOI： 10.1016/0022-1759(93)90266-a

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN： 0022-1759            Impact factor:   2.303


× No keyword cloud information.
  8 in total

1.  Two differentially expressed interleukin-11 receptor genes in the mouse genome.

Authors:  P Bilinski; M A Hall; H Neuhaus; C Gissel; J K Heath; A Gossler
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

2.  Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor.

Authors:  J Karow; K R Hudson; M A Hall; A B Vernallis; J A Taylor; A Gossler; J K Heath
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

3.  Interleukin-6 involvement in mesothelioma pathobiology: inhibition by interferon alpha immunotherapy.

Authors:  H Bielefeldt-Ohmann; A L Marzo; R P Himbeck; A G Jarnicki; B W Robinson; D R Fitzpatrick
Journal:  Cancer Immunol Immunother       Date:  1995-04       Impact factor: 6.968

4.  Interleukin-6 does not mediate the stimulation by prostaglandin E2, parathyroid hormone, or 1,25 dihydroxyvitamin D3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones.

Authors:  I Holt; M W Davie; I P Braidman; M J Marshall
Journal:  Calcif Tissue Int       Date:  1994-08       Impact factor: 4.333

5.  Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model.

Authors:  H Bielefeldt-Ohmann; D R Fitzpatrick; A L Marzo; A G Jarnicki; R P Himbeck; M R Davis; L S Manning; B W Robinson
Journal:  Cancer Immunol Immunother       Date:  1994-12       Impact factor: 6.968

6.  Serum interleukin-6, soluble interleukin-6 receptor and Crohn's disease activity.

Authors:  Stéphane Nancey; Nadim Hamzaoui; Driffa Moussata; Ivan Graber; Jacques Bienvenu; Bernard Flourie
Journal:  Dig Dis Sci       Date:  2007-06-05       Impact factor: 3.199

7.  Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.

Authors:  V Poli; R Balena; E Fattori; A Markatos; M Yamamoto; H Tanaka; G Ciliberto; G A Rodan; F Costantini
Journal:  EMBO J       Date:  1994-03-01       Impact factor: 11.598

8.  Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras.

Authors:  R G Hawley; A Z Fong; B Y Ngan; V M de Lanux; S C Clark; T S Hawley
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.